Back to Trials
NCT00515567Recruiting

Explanted Lung Tissues With Pulmonary Fibrosis

University of Chicago

Start Date

2/1/2006

Completion Date

12/1/2026

Summary

The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.

Detailed Description

Pulmonary Fibrosis involves scarring of the lung. Gradually, the air sacs of the lungs become replaced by fibrotic tissue. The most current thinking is that the fibrotic process is a reaction to tiny injury to the lung. When the scar forms, the tissue becomes thicker causing a permanent loss of the tissue's ability to carry oxygen into the bloodstream. We need to obtain lung tissue from patients without pulmonary fibrosis and compare it to lung tissue from patients with pulmonary fibrosis.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * all patients awaiting lung transplant Exclusion Criteria: * all who will not give consent

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pulmonary Fibrosis

Locations

The University of Chicago

Chicago, Illinois 60637

United States